Plasmapheresis for diffuse alveolar hemorrhage in a patient with Wegener's granulomatosis: Case report and review of the literature

Journal of Clinical Apheresis

Volumn 20, Issue 4, 2005, Pages 230-234

  Nguyen, Thong ^a   Martin, Meri King ^a   Indrikovs, Alexander J ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

c ANCA; Diffuse alveolar hemorrhage; Glomerulonephritis; Therapeutic plasma exchange; Wegener's granulomatosis

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; HEMOSIDERIN; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RHEUMATOID FACTOR;

ADULT; ANAMNESIS; ANEMIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; ERYTHROCYTE SEDIMENTATION RATE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; INTUBATION; KIDNEY; KIDNEY BIOPSY; KIDNEY FAILURE; LUNG; LUNG FUNCTION; LUNG HEMORRHAGE; LUNG LAVAGE; MALE; PLASMAPHERESIS; POLYARTHRITIS; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; SINUSITIS; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT; VASCULITIS; WEGENER GRANULOMATOSIS; BLEEDING; LUNG ALVEOLUS; NEUTROPHIL CHEMOTAXIS; NOSE MUCOSA; PATHOLOGY; SKIN;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; HEMORRHAGE; HUMANS; MALE; NASAL MUCOSA; NEUTROPHIL INFILTRATION; PLASMAPHERESIS; PULMONARY ALVEOLI; SKIN; WEGENER GRANULOMATOSIS;

EID: 33644971970     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20069     Document Type: Article

References (15)

1. Kamesh L, Harper L, Savage COS. ANCA-positive vasculitis. J Am Soc Nephrol 2002;13:1953-1960.
2. Davies DJ, Moran JE, Niall JF, Ryan GB. Segmental necrotizing glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br Med J (Clin Res) 1982;285:606.
3. Cohen Tervaert JW, Huitema MG, Hené RJ, Sluiter WJ, The TH, van der Hem GK, et al. Relapses of Wegener's granulomatosis: prevention by treatment based on antineutrophil cytoplasmic antibody titre. Lancet. 1990;336:709-711.
4. Harper L, Savage COS. Pathogenesis of ANCA-associated systemic vasculitis. J Pathol 2000;190:349-359.
5. Falk RJ, Jennette JC. ANCA are pathologenic: oh yes they are! J Am Soc Nephrol 2002;13:1977-1979.
6. Savage COS, Harper L, Holland M. New findings in pathogenesis of antineutrophil cytoplasm antibody associated vasculitis. Curr Opin Rheumatol 2002;14:15-22.
7. Preston GA, Yang JJ, Xiao H, Falk RJ. Understanding the pathogenesis of ANCA: where are we today? Cleve Clin J Med 2002;69 (Suppl 2):SII51-4.
8. Dail D, Hammar S. Pulmonary pathology, 2nd ed. New York: Springer-Verlag; 1994. p 1028-1038.
9. Falk RJ, Nachman PH, Hogan SL, Jennette JC. ANCA glomerulonephritis and vasculitis: A Chapel Hill perspective. Semin Nephrol 2000;20:233-243.
10. Lockwood CM, Boulton-Jones JM, Lowenthal RM, Simpson IJ, Peters DK. Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis. Br Med J 1975;2:252-254.
11. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ: Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kid Dis 2003;42:1149-1153.
12. Tesar V, Rihova Z, Jancova E, Rysava R, Merta M. Current treatment strategies in ANCA-positive renal vasculitis: lessons from European randomized trials. Nephrol Dial Transplant 2003;18(Suppl 5):v2-v4.
13. Brecher ME, editor. Technical manual, 14th ed. American Association of Blood Banks, 2002. pp 132-136.
14. Owen HG, Brecher ME. Management of the therapeutic apheresis patient. In: McLeod BC, Price TH, Drew MJ, editors. Apheresis: principles and practice. Bethesda, MD: AABB Press; 1997. pp 225-226.
15. McLeod BC. Introduction to the third special issue: Clinical applications of therapeutic apheresis. J Clin Apheresis 2000;15:2-3.